Back To Search Results

Benign Orbital Tumors

Editor: Eva Chou Updated: 8/8/2023 2:00:05 AM


The orbit contains many vital structures and tissues. Masses in this confined space can rapidly cause visually significant symptoms, up to and including irreversible vision loss. These masses may be neoplastic, inflammatory, or infectious. This article will review primary benign neoplasms of the adult orbit with a focus on epidemiology, pathogenesis, diagnosis, and treatment.

While often discussed in the context of orbital tumors, neoplasms of the lacrimal gland, intraocular, and periocular tissues are outside the scope of this article. In addition to a careful history, understanding epidemiology and risk factors can significantly streamline further workup and eventual diagnosis of orbital tumors.

Orbital Anatomy

The orbit is a confined space with well-demarcated anatomical landmarks. The orbital cavities are generally symmetric, with parallel medial walls and tapering dimensions posteriorly to the apex. The medial wall of the orbit is composed of the ethmoid, lacrimal, maxillary, and lesser wing of the sphenoid bones. The lamina papyracea is the thinnest part of the orbit and separates the medial orbit from the ethmoid sinuses.

The orbital roof comprises part of the frontal bone and the lesser wing of the sphenoid bone and contains the lacrimal gland fossa, the trochlear fossa, and the supraorbital notch or foramen.

The thicker lateral orbital wall is composed of the zygomatic bone and the greater wing of the sphenoid bone. The lateral wall extends anteriorly to the equator of the globe, allowing for a temporal field of vision. Lateral wall landmarks include the lateral Whitnall tubercle, Whitnall ligament, and the frontozygomatic suture.

The orbital floor is composed of the maxillary, palatine, and zygomatic bones. The maxillary division of the trigeminal nerve and the infraorbital artery travel along the infraorbital groove and canal. The optic canal, superior orbital fissure, and inferior orbital fissure contain the critical neurovascular structures of the orbit. The arterial blood supply of the orbit is via the ophthalmic artery, a branch of the internal carotid artery. Anastomotic branches in communication with the external carotid form a network to further supply the periorbital region. The superior and inferior ophthalmic veins provide the primary venous drainage of the orbit. 

Orbital masses can therefore cause significant cosmetic and functional disturbances of varying degrees depending on specific location and size. Knowledge of orbital anatomy in conjunction with judicious imaging is essential to diagnose and manage orbital tumors appropriately.


Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care



Primary orbital tumors can be classified according to the tissue of origin (Table 1).

Table 1. Benign orbital tumors and their tissues of origin.




  • Epidermoid cyst
  • Dermoid cyst
  • Mucocele
  • Hematic pseudocyst
  • Meningoencephalocele
  • Apocrine hidrocystoma
  • Colobomatous cyst


  • Cavernous hemangioma
  • Lymphangioma
  • Orbital varix
  • Capillary hemangioma
  • Intravascular papillary endothelial hyperplasia


  • Schwannoma
  • Neurofibroma
  • Granular cell tumors
  • Meningioma
  • Optic nerve glioma
  • Paraganglioma


  • Fibrous histiocytoma
  • Giant cell angiofibroma
  • Hemangiopericytoma
  • Myofibroma

Osseous or fibro-osseous

  • Fibrous dysplasia
  • Osteoma
  • Ossifying fibroma
  • Chondroma
  • Giant cell granuloma


  • Dermolipoma
  • Lipoma


  • Plasmacytoma
  • Benign reactive lymphoid hyperplasia

Cystic Tumors 

  • Epidermoid cyst
  • Dermoid cyst
  • Mucocele
  • Hematic pseudocyst
  • Meningoencephalocele
  • Apocrine hidrocystoma
  • Colobomatous cyst

Epidermoid cysts rarely form in the orbit but must be considered in the differential for deep orbital cystic lesions. They may present as primary congenital lesions or form following the traumatic displacement of surface epithelium.[1] Histologically, epidermoid cysts are lined by stratified squamous epithelium and contain desquamated keratin lamellae. 

Epidermoid cysts should not be confused with dermoid cysts, which are characterized by the presence of mesodermal elements. Dermoid cysts account for nearly half of childhood orbital tumors but are rarely diagnosed in adulthood.[2] 

Mucoceles are cystic cavities that contain sterile mucus. They typically form secondary to outflow obstruction of the frontal and ethmoidal sinuses. These masses rarely form and are slow-growing. However, when large enough, they can invade the orbit and cause symptoms similar to those seen in other orbital masses. Mucoceles have been more often reported in patients with a history of trauma or sinus surgery.[3] Histologically, these cysts are lined by simple epithelium and may include acute or chronic inflammatory material.

Hematic pseudocysts are also rarely-reported orbital lesions. The most common presentation of a hematic cyst is acute-onset proptosis following remote trauma to the orbit.[4] Chronic orbital hematic cysts have also been reported and are histologically similar to chronic subdural hematomas.[5][6] These lesions are cystic and contain blood and/or blood breakdown products. Depending on the chronicity of the mass, products of inflammatory or granulomatous reactions may also be present.

Defects in the orbital roof allow for the herniation of intracranial tissue into the orbit, forming meningoencephaloceles. Although rare, these intraorbital masses are important to consider in patients presenting with signs of a superior or superonasal orbital mass. Meningoencephaloceles are on the differential for pulsatile proptosis, along with carotid-cavernous fistulas and vascular tumors.[7] Radiographic studies are crucial in diagnosing these masses since inappropriate biopsy or resection can lead to devastating outcomes.

Apocrine hidrocystomas are common lid lesions but rarely reported inside the orbit.[8] They are cystic lesions characterized histologically by a capsule composed of bilaminar, columnar epithelium with outpouchings of the lumen ("apocrine snouts"). These lesions are prone to recurrence if the capsule is not completely excised.[9]

Colobomatous cysts of the orbit are rare, congenital anomalies that occur secondary to embryogenesis abnormalities. Since these cysts appear at birth and are diagnosed in infancy or childhood, they will not be discussed in detail here.  

Table 2. Key features of cystic orbital tumors.


Clinical features

Radiographic features


Epidermoid cyst

  • Variable presentation
  • Congenital or acquired following trauma 
  • Lobulated lesions, often with a hypodense center and sclerotic border
  • Stratified squamous epithelial cell wall containing a granular layer and keratin lamellae 

Dermoid cyst

  • 3 to 9% of all orbital masses
  • More common in children
  • Subcutaneous mass near orbital rim; firm, fixed, painless
  • Most often superotemporal or superonasal rim, corresponding to bony sutures
  • Well-circumscribed cystic lesion 
  • Keratinized epithelium capsule with internal adnexal structures (e.g., hair follicles, sweat glands)


  • ~1% of all orbital tumors 
  • Adults with symptoms of chronic rhinosinusitis
  • Variable, depending on contents of mucocele
  • Adjacent sinus opacification, bony erosion
  • Cystic mass lined by pseudostratified ciliary/columnar epithelium

Hematic pseudocyst

  • May present with acute-onset proptosis following remote trauma to the orbit
  • Chronic lesions present with similar signs and symptoms as other slow-growing orbital masses
  • Well-circumscribed, hypodense, non-enhancing cystic structure on CT
  • High-intensity lesion on T1 and T2 MRI
  • Cystic mass containing blood and/or blood breakdown products


  • <1% of all orbital tumors
  •  Congenital in children or acquired after craniofacial trauma
  •  Anterior mass: fluctuant, smooth swelling near the medial canthus
  •  Posterior mass: pulsating proptosis, strabismus
  • Cystic or solid mass
  • May locate defects in medial orbital wall or roof with herniation of intracranial contents
  • Brain tissue, meninges

Apocrine hidrocystoma

  • Common lid lesions rarely grow within the orbit
  • Presentation varies depending on the location of the mass
  • Thin-walled, well-circumscribed cystic mass
  • Capsule composed of bilaminar, columnar epithelium
  • Contain areas of luminal outpouching ("apocrine snouts")

Vasculogenic Tumors

  • Cavernous hemangioma
  • Lymphangioma
  • Orbital varix
  • Intravascular papillary endothelial hyperplasia
  • Capillary hemangioma

Tumors of vasculogenic origin constitute approximately 17% of all orbital masses.[2] The Orbital Society has classified certain vascular lesions based on the type of vascular flow.[2][10] The use of imaging with contrast is especially helpful in the diagnosis of these lesions, as they are often characterized by vascular flow with specific filling patterns.

The cavernous hemangioma, also known as a cavernoma, is the most common benign primary orbital tumor in adults.[2] These lesions have slow vascular flow and low pressure, which makes their risk of hemorrhage lower than other vascular lesions. They often present in middle age with slowly progressive proptosis and vision changes. Presentation during pregnancy is common due to hormonal-associated growth and increased risk of hemorrhage.[11] Histologically, these are encapsulated lesions characterized by dilated vascular spaces separated by connective tissue. 

Lymphangiomas, also known as lymphatic malformations, involve both vascular and lymphatic systems. They have no vascular flow and are most prevalent in the 1st-2nd decade of life.[2][10] Loose connective tissue stroma surrounds the lymphatic channels on histology. 

In contrast to lymphangiomas, orbital varices typically present with intermittent proptosis or diplopia during Valsalva maneuvers due to their venous flow. These vascular malformations can bleed and are the most common cause of spontaneous orbital hemorrhage.[12][13] They account for less than 2% of all orbital masses and are most often diagnosed before the 3rd decade of life.[13] 

Secondary orbital varices may form in the setting of intracranial arteriovenous malformation and carotid-cavernous fistulas. Imaging in conjunction with the clinical exam is often sufficient to diagnose orbital varices, and these lesions are classified histologically as dilated venous channels lined by endothelial cells. Chronic inflammatory changes and fibrosis may also be present on histology.  

Another rare vascular mass with a propensity to bleed during resection is a Masson tumor, also known as intravascular papillary endothelial hyperplasia. These tumors have been rarely reported in the orbit and typically require histopathologic confirmation. Histologically, the lesion is characterized by papillary proliferation of vascular endothelial cells, both on the surface of the mass and within lumens of blood vessels.[14][15]

Capillary hemangiomas are rarely diagnosed in adulthood. They are typically lobular masses that enhance on imaging and reveal well-developed capillary channels on histology.  

Table 3. Key features of vasculogenic orbital tumors.


Clinical features

Radiographic features


Cavernous Venous Malformation/Cavernous Hemangioma

  • Most common benign orbital tumor
  • 2nd-4th decades
  • 60% of patients are female
  • Accelerated growth during pregnancy
  • Painless, progressive proptosis
  • Well-circumscribed intra- or extra-conal mass
  • Contrast-enhanced imaging early stippled pattern with late homogeneous enhancement 
  • Encapsulated cavernous spaces with smooth muscle walls

Orbital Lymphatic Malformation/ Lymphangioma

  • 0.3 to 4% of all orbital tumors
  • 1st-2nd decade of life; affects men and women equally 
  • Progressive mass effect
  • Proptosis does not worsen with Valsalva 
  • Multiple loculations with air-fluid levels
  • Large serum-filled lymphatic channels lined by lymphatic endothelium; interstitial lymphoid tissue

Distensible Venous Malformation / Varix

  • 0 to 1.3% of all histopathologically proven orbital masses
  • 1st-3rd decade of life; affects men and women equally 
  • Intermittent, positional proptosis that worsens with Valsalva
  • Irregular mass or dilated, tortuous vessel
  • Lack internal septae
  • Vascular channels lined with endothelial cells, interstitial fibrosis

Intravascular Papillary Endothelial Hyperplasia

  • Rarely reported
  • Variable presentation depending on location
  • Round/oval-shaped, well-defined mass that is iso- to hyper-intense on T1 and T2 MRI
  • Exuberant endothelial papillary proliferation, both on the surface of the mass and within lumens of blood vessels

Capillary Hemangioma

  • Most common benign orbital tumor in children
  • 3% of all orbital tumors
  • Variable presentation depending on location
  • Lobulated, enhancing mass
  • Ultrasound: hyperechoic, compressible; high internal reflectivity 
  • MRI: hypo-intense on T1 and iso- to hyper-intense on T2 with serpiginous flow voids 
  • Lobular mass composed of well-developed capillary channels

Neural Tumors

  • Schwannoma
  • Neurofibroma
  • Meningiomas
  • Optic nerve glioma
  • Paraganglioma

Orbital Schwannomas, also known as neurilemomas, are peripheral nerve sheath tumors and account for only 1% of all orbital tumors.[2] While patients with Neurofibromatosis (NF) are more likely to have head and neck schwannomas with orbital involvement, the risk of orbital schwannomas in these patients is only slightly higher than in the general population. Schwannomas present in one of four histologic subtypes, all stain positively for S-100, SOX10, p16, and neurofibromin. The four histologic variants include cellular, melanotic, plexiform, and neuroblastoma.[16]

Another peripheral nerve sheath tumor that is more classically associated with NF is the neurofibroma. The plexiform neurofibroma, a mass of large tortuous nerve fascicles, is the most common subtype diagnosed within the orbit, accounting for 2% of orbital tumors.[17] In contrast with schwannomas, neurofibromas are histologically composed of transformed Schwann cells within the fibrous, non-neoplastic stroma.

Modified Schwann cells have also been reported as the origin of granular cell tumors (GCTs).[18] These tumors are immunoreactive for S100 and myelin basic protein.[19] GCTs are rare tumors, of which about 3% rise in orbit.[20][21] Within the orbit, they most often arise inferiorly and may involve the extraocular muscles. Although often well-circumscribed and considered benign, there have been reports of infiltrative GCTs. Thus, excision is often recommended.

Meningiomas are common primary intracranial tumors that rarely arise from within the orbit. Orbital meningiomas account for approximately 4% of all orbital masses.[2] Optic nerve sheath meningiomas (ONSM) arise in orbit, often present during middle age, and are three times more common in females.[22] They are one of the few orbital tumors that can cause optociliary shunt vessels, which are collaterals formed in the setting of chronic central retinal vein occlusion. Sphenoid wing meningiomas are the most common intracranial tumors that can directly extend to the orbit.[23] Histologically, meningiomas arise from the leptomeninges, specifically from arachnoid cap cells. Certain features classically associated with meningiomas include psammoma bodies, whorl formations, and nuclear pseudoinclusions.[24]

Another orbital tumor commonly seen in NF is the optic nerve glioma (ONG), which is histologically consistent with a pilocytic astrocytoma, most often low-grade with variable cytology and cellularity. ONG is important to consider as the differential when a young patient presents with acute-onset vision loss. Although generally considered benign, it is often difficult to distinguish between reactive and neoplastic resection margins, as these tumors are more aggressive with malignant potential.[25] Optociliary shunt vessel formation may be seen in patients with ONG, though less commonly than in patients with ONSM. 

Paragangliomas of the orbit are extremely rare neoplasms of neuroendocrine tissue. Similar to other slow-growing orbital masses, the reported cases presented with gradually worsening proptosis.[26] These tumors are characteristically present with a "salt and pepper" appearance on MRI due to their high vascularity and flow voids.[27]

Table 4. Key features of neural orbital tumors.


Clinical features

Radiographic features



  • 1% of orbital tumors
  • 2nd-6th decade of life
  • Gradual non-pulsating proptosis; EOM restriction, optic neuropathy
  • Smooth, round/elongated, homogenous lesions
  • Grow along the orbital axis
  • Biphasic with patches of Antoni A and Antoni B patterns
  • Strongly positive S-100 stain


  • 2 to 4% of orbital tumors
  • Plexiform: 1st decade, almost always associated with NF1
  • Localized: 3rd-5th decade 
  • Progressive proptosis, EOM restriction, ptosis, optic neuropathy
  • Smooth ovoid lesions with variable contrast enhancement
  • Loosely arranged bundles of perineural cells, fibroblasts, and Schwann cells with surrounding pseudocapsule
  • Positive S-100 stain

Granular Cell Tumor

  • Rare; 3% arise in the orbit
  • Most often arise inferiorly and may involve extraocular muscles (e.g., inferior rectus)
  • Localized: around the 4th decade 
  • No gender preference
  • Often well-defined/well-circumscribed; may be fusiform in appearance 
  • Hypo-intense to muscle on T1 MRI
  • Significant peripheral enhancement in post-contrast imaging
  • Polygonal cells, clear nuclei, highly eosinophilic
  • Lesions with higher mitoses, nuclear pleomorphism, necrosis, and spindled cells are concerning for malignancy
  • Stains positive for S-100, P0, and Myelin Basic Protein

Optic nerve sheath meningioma

  • 2% of all orbital tumors
  • 4th-5th decade of life
  • Women 3x more likely affected
  • Gradual painless vision loss, optic atrophy; optociliary shunt vessels
  • Smooth, tubular, enhanced with calcifications
  • "Tram tracking" sign (axial) or "doughnut" sign (coronal) on MRI
  • Arise from optic nerve sheath meningeal cells
  • May have psammoma bodies

Sphenoid wing meningioma

  • NF2 patients
  • 2.5x more common in females
  • Proptosis, vision loss, temporal fullness, ptosis, restricted EOMs
  • Homogeneously enhancing with calcification
  • Conform around and compress surrounding structures
  • Whorls of meningothelial cells, ovoid nuclei
  • May have psammoma bodies

Optic Nerve Glioma

  • 1.5 to 4% of orbital tumors
  • Often in children (90% within the first two decades of life)
  • MRI is the imaging of choice and reveals relative iso- to hypo-intense enlargement of nerve on T1
  • Proliferation of astrocytes with pilocytic appearance and spindle-shaped nuclei
  • May contain microcystic areas, Rosenthal fibers, calcification


  • Extremely rare
  • Proptosis, change in vision, EOM restriction
  • Well-defined homogeneous lesion
  • Salt and pepper appearance on T1 MRI
  • Epithelioid chief cells in clusters; neuro-secretory granules

Fibrocystic Tumors

  • Fibrous histiocytoma
  • Giant cell angiofibroma
  • Hemangiopericytoma
  • Myofibroma

An assortment of benign and malignant mesenchymal tumors can arise within the orbit. Solitary fibrous tumors (SFT) encompass a spectrum of lesions with similar histopathologic morphology. These include fibrous histiocytoma, hemangiopericytoma, and giant cell angiofibroma.[28] Histologically, this group of tumors contains cellular and stromal components arranged in what has been called a "patternless pattern" with "staghorn" vessels.[29] Importantly, SFTs may b, e malignant, invasive, and locally destructive lesions. Often the histologic evaluation is crucial in distinguishing between a benign and malignant lesion. For example, more indolent, fat-forming STFs contain mature adipose tissue and few to no mitotic cells. Dedifferentiated SFT signifies a more aggressive lesion.[29]

In adults, fibrous histiocytoma is considered the most common mesenchymal tumor of the orbit.[30] It is most often benign, though it has malignant potential, and is commonly diagnosed in middle-aged adults. Malignant fibrous histiocytomas should be considered in the differential, especially in patients who have previously undergone radiation to the orbit. They contain the histologic features mentioned above. Immunohistochemical staining is essential to rule out other neoplasms, including schwannoma and melanoma. 

Giant cell angiofibromas are benign, highly-vascularized soft tissue tumors found in the head and neck region and rarely arise within the orbit. While they may have an indolent course, some grow more rapidly and can resemble malignancy.[31]

Hemangiopericytomas account for about 1% of all orbital tumors and most often occur around middle age. Up to nearly half of hemangiopericytomas can metastasize, and their malignant potential is difficult to predict.[32]

Another rare soft tissue mass that can arise in the orbit is the myofibroma. These are more often seen in children, but cases have been reported in adults.[33] On imaging, these tumors are well-circumscribed and enhance with contrast. Histopathologic characteristics of myofibroma include spindle cells arranged in short fascicles with scant cytoplasm and thin-walled, branching vessels.

Table 5. Key features of fibrocystic orbital tumors.


Clinical features

Radiographic features


Fibrous Histiocytoma

  • Most common primary mesenchymal tumor of the orbit
  • Middle age (40-60 years)
  •  Well-circumscribed, mixed solid and cystic components; mildly enhancing on T1 and T2 MRI
  • Cellular and stromal components are arranged in a "patternless pattern" with "staghorn" vessels

Giant Cell Angiofibroma

  • More often affects women
  • Presents within the first two decades of life
  • Well-circumscribed, uniformly-enhancing with intermediate signal intensity on MRI
  • Patternless spindle cell proliferation with rich vasculature
  • Stains positive for vimentin and CD34


  • 1-3% of all biopsied orbital lesions
  • 4th decade of life
  • Affects men and women equally
  • Proptosis, restricted EOMs, visual decline
  • Difficult to differentiate from other SFTs on imaging
  • Well-circumscribed, isointense to gray matter on T1 and T2 MRI
  • Typically in superior orbit
  • Spindle-cell proliferation with thin-walled, branching vessels ("staghorn" vessels)
  • Encapsulated


  • Most often diagnosed in children
  • Well-circumscribed; isointense to muscle on T1 MRI, hyperintense on T2 MRI
  • Spindle cells arranged in short fascicles with scant cytoplasm and thin-walled, branching vessels

Osseous and Fibro-osseous Tumors

  • Fibrous dysplasia
  • Osteoma
  • Ossifying fibroma
  • Chondroma
  • Giant cell granuloma 

Osseous and fibro-osseous tumors of the orbit constitute about 2% of all orbital masses.[2]

Fibrous dysplasia is a disorder of bone that can affect the craniofacial skeleton. It represents up to 7% of all primary orbital bone tumors.[34] Patients often present with progressive pain and disfigurement at the affected site. The bony growth can lead to mass effect within the orbit, increasing the risk of optic nerve compression and injury.[35] Optic nerve decompression may be indicated to preserve vision in these cases. Symptomatic fibrous dysplasia is often treated with surgical intervention. Histologically, the affected bone is dysplastic, revealing dense fibrous stroma with low to moderate cellularity.

Osteomas are common paranasal sinus tumors that can involve the orbit. Primary orbital osteomas are very rare, making up less than 1% of orbital tumors. Depending on the location of the mass, surgical intervention may include sculpting or repair of the bone to restore the natural orbital contour.[36]

Ossifying fibromas (OF) are benign bone lesions with three different variants: cemento-OF (COF), juvenile trabecular OF (JTF,) and juvenile psammomatoid OF (JPOF). Of these, COF and JTOF are almost exclusively present in the jaw. JPOF often presents by the 3rd decade and can involve the orbit.[37] Psammomatoid bodies are small ossicles that resemble psammoma bodies. Histologically, they are seen embedded in the stroma with spindle and stellate cells.  

Chondromas are benign cartilaginous tumors that very rarely occur in the head and neck region and constitute less than 1% of all orbital tumors. Chondromas may arise within the orbit from the trochlea, which is the only purely cartilaginous structure present.[38] Their potential for malignancy is not well-defined.

Giant cell (reparative) granulomas (GCRG) have been defined as benign fibro-osseous proliferation and are most often reported in the jaw. Rarely these lesions can rarely arise in the orbit.[39] Although benign, these lesions can potentially be locally aggressive and destructive.[40] Giant cell granulomas are more often diagnosed in women within the first two decades of life.[41] Recent studies have treated GCRG by sculpting the bone and removing the abnormal tissue without sharp excision.[40]

Table 6. Key features of osseous and fibro-osseous orbital tumors.


Clinical features

Radiographic features


Fibrous dysplasia

  • Monostotic form presents in 2nd-3rd decade of life
  • Polyostotic form presents in childhood and is seen in McCune-Albright Syndrome
  • "Pagetoid" pattern of radiolucent and radiopaque areas on CT
  • MRI reveals isointense lesions that moderately enhance with gadolinium 
  • Dense fibrous stroma, low to moderate cellularity
  • Stroma may contain myxomatous areas, bone cysts


  • Very rarely primary orbital tumors
  • May extend from sinuses
  • CT is modality of choice and demonstrates focal area of lucency, surrounded by sclerotic bone
  • Mature lamellar and woven bone mixture
  • Osteoblasts outline the rim and osteocytes within the matrix

Ossifying fibroma (JPOF variant)

  • JPOF variant presents by the 3rd decade of life
  • Well-circumscribed lesion with varying degrees of soft tissue and bone density on CT
  • Psammomatoid bodies embedded in the stroma with spindle and stellate cells


  • Very rare
  • Present in 3rd-4th decade of life
  • Well-defined, minimal enhancement
  • Mature chondrocytes 

Giant cell granuloma

  • Present by 2nd decade of life
  • Female predominance
  • Well-defined osteolytic mass arising from the orbital wall with varying degrees of mineralization 
  • Most often affect the orbital roof and lateral orbital wall
  • Multinucleated foreign body giant cells intermingled with inflammatory cells, lymphocytes

Lipomatous Tumors

  • Dermolipoma
  • Lipoma 

Dermolipomas constitute approximately 3% of all orbital tumors and may be mistaken for orbital fat prolapse as both occur in the lateral canthal area. Dermolipomas are often unilateral and occur in younger patients.[42] They should be distinguished from orbital lipomas, which account for less than 1% of all orbital tumors due to the difference in management. While lipomas are often excised in full, surgical excision of dermolipomas is often conservative and confined to portions of the mass that are readily visible.[43]

Table 7. Key features of lipomatous orbital tumors.


Clinical features

Radiographic features



  • 3% of all orbital tumors
  • Present similarly to orbital fat prolapse
  • Smooth, well-demarcated
  • Bright on T1 and T2 MRI
  • Mature adipose tissue and dermal-like connective tissue 


  • 0.6% in the orbital region
  • The average age is 35 years
  • Proptosis
  • Well-circumscribed
  • Displaces surrounding structures
  • Lobulated, mature adipose tissue

Lymphoid Tumors

  • Plasmacytoma
  • Benign reactive lymphoid hyperplasia

Plasmacytomas are plasma cell tumors that can arise from soft tissue or bone. More commonly, secondary metastatic plasmacytomas arise as a consequence of multiple myeloma. Importantly, primary plasmacytomas cannot be differentiated from metastatic lesions on histopathology.[44] The plasma cell morphology is heterogeneous with the presence of multinucleated cells and scant stroma. Patients diagnosed with plasmacytoma should undergo further work-up for systemic disease.

Lymphocyte proliferation in the orbit can present in one of a few entities. The first is benign reactive lymphoid hyperplasia (BRLH), which has been categorized under inflammatory or granulomatous as opposed to neoplastic.[45] It most often presents as a salmon-colored lesion on the nasal conjunctiva.[46] Histologically, BRLH has been distinguished from orbital inflammatory syndrome and is typically characterized by slow proliferation of lymphocytes without other markers of malignancy (e.g., Bcl-2 marker).[47] 

When considering the diagnosis of BRLH, it is crucial to consider more aggressive processes such as atypical lymphoid hyperplasia, lymphoma, and other malignancies on the differential. Treatment of BRLH involves corticosteroids, external beam radiation therapy, and rituximab.[47]

Table 8. Key features of lymphoid orbital tumors.


Clinical features

Radiographic features



  • Rare; may be metastatic in patients with multiple myeloma
  • Well-defined lytic lesion
  • Extraconal in 90% of cases
  • Arise in posterior orbit 69% of the time
  • Heterogeneous plasma cells with scant stroma
  • Stain positive for CD138 

Benign reactive lymphoid hyperplasia

  • Predilection for male gender
  • Often in superior orbit
  • Heterogenous, low attenuation on CT; conform to the shape of the globe
  • Follicles composed of reactive lymphocyte proliferation
  • Negative Bcl-2 marker


The incidence of primary orbital tumors is low, affecting approximately 1 in 100,000 people.[48] Most primary orbital tumors are benign, with an increased risk of malignancy in patients over 60 years of age.[49] In adults, most primary benign orbital tumors are diagnosed equally in male and female patients, although some subtypes, including cavernous hemangiomas and meningiomas of the optic nerve sheath and sphenoid wing, are more common in females.[50][51][52] Geography and race have not yet been established as risk factors for primary orbital tumors in adults.

A large retrospective series of 2,480 orbital lesions referred to a specialized center for tissue diagnosis identified benign masses in 68% of cases.[49] Of these, the most common tumors were dermoid cysts (14%), followed by cavernous hemangiomas (9%).

Most tumors were located in the upper outer orbital quadrant, and the authors noted that tumors in the lower inner quadrant have a higher likelihood of malignant disease. Additional patterns were identified, with different lesions presenting most commonly in different anatomic locations. In the upper outer quadrant, dermoid cysts were the most common tumors identified. Most masses in the upper inner quadrant were mucoceles.

Cavernous hemangiomas were the most common masses found in the lower outer quadrant, and basal cell epitheliomas made up the highest number in the lower inner quadrant. The most common central orbital masses were meningiomas.


The orbital masses discussed in this article are tumors. These tumors are categorized by the origin of cell type. The differential for these orbital masses includes those that arise due to inflammation, infections, or other pathologic processes.


The histopathology of benign orbital tumors varies widely, depending on the tissue of origin. Histopathologic features of the orbital tumors discussed in this article can be found in Tables 2-8.

History and Physical

Space-occupying orbital lesions produce a variety of ocular signs and symptoms (Table 9). Presenting signs due to orbital masses most commonly include proptosis, extraocular muscle limitation, either restrictive or paralytic, chemosis, exposure keratopathy, and optic neuropathy. Additionally, patients typically present with eye and periocular pain, loss of vision, diplopia, a change in the appearance of the eye or eyelids, a pulsatile sensation, irritation, and rarely a visible mass. Slow-growing lesions are typically painless; however, acute changes, including lesion rupture or hemorrhage, can result in sudden onset of pain and other orbital symptoms.

Recommended clinical examination to evaluate patients with a suspected orbital tumor includes the following:

  • Visual acuity and refraction with attention to asymmetry or a hyperopic shift
  • Pupillary assessment in multiple directions of gaze to assess the presence of a relative afferent pupillary defect and dynamic optic nerve compression
  • Color vision testing to assess for subtle optic neuropathy
  • Intraocular pressure to screen for secondary ocular hypertension due to mass effect or impaired venous drainage
  • Extraocular motility to evaluate for restrictive or paralytic muscle limitations 
  • Hertel exophthalmometry to quantify proptosis and establish a baseline for future comparison 
  • Dilated fundus exam to assess for optic nerve asymmetry, pallor, and choroidal folds
  • Optical coherence tomography retinal nerve fiber layer (OCT RNFL) and Humphrey visual field (HVF) 30-2 to further assess and quantify the degree of optic neuropathy

Table 9. Common presenting signs and symptoms of orbital tumors and their potential mechanisms.

Signs and Symptoms

Potential Mechanism(s)

Decreased visual acuity

Compressive optic neuropathy; ocular surface disease; glaucoma

Orbital pain or paresthesia

Mass effect; rapid expansion; nerve compression

Eyelid edema

Inflammatory response; impaired venous outflow


Impaired venous outflow; secondary to surface inflammation 

Ocular hypertension

Direct mass effect or secondary tissue swelling with increased hydrostatic pressure around the globe; mass effect with increased episcleral or orbital venous pressure; rarely secondary angle closure


Mass effect with anterior displacement of the globe

Globe displacement

Mass effect with vertical displacement of the globe


Mass effect with globe displacement or adhesion to globe; restrictive or paralytic extraocular muscle limitation; symptomatic anisometropia

Hyperopic shift

Mass effect with posterior globe flattening decreased axial length


Mass effect; neuropathy; altered globe position

Gaze-evoked amaurosis

Gaze-dependent optic nerve compression


Many benign orbital tumors have similar clinical presentations. Although patient history and exam findings may help distinguish between certain types of orbital masses, imaging is often necessary for diagnosis. 

Computed tomography (CT) or magnetic resonance imaging (MRI) can provide important diagnostic information and guide surgical management. Initial imaging with CT is often recommended to assess orbital/bony anatomical landmarks. Using contrast and arterial phase imaging is especially helpful for characterizing masses and developing a differential diagnosis. When a more detailed anatomic definition is required, MRI, with and without contrast, is often obtained. Ultrasound imaging is less commonly used but can provide fast diagnostic information for masses located in the anterior orbit.

Treatment / Management

General Considerations

The presence or absence of symptoms often dictates management decisions for benign orbital masses. In many cases, small and asymptomatic tumors can be observed closely with annual exams. Exceptions to this include tumors with a high potential for malignancy.

Medical Management

Most primary orbital tumors cannot be treated with medical management. There have been reported cases of severe lymphatic malformations and lymphangiomas that have responded to Sildenafil (PDE-5 inhibitor) and Sirolimus (mTOR inhibitor).[53][54][55](B3)

Surgical Management

Surgical excision is warranted in orbital masses that cause symptoms, particularly vision changes, proptosis, and extraocular movement restriction. The risk of recurrence may be high with some primary orbital tumors, including lymphangiomas and incompletely-excised cavernous hemangiomas. Hemangiopericytomas should be surgically resected due to their relatively high potential for malignancy.

Certain orbital tumors, such as orbital varices and optic nerve sheath meningiomas, are difficult to resect due to the risk of hemorrhage or proximity to vital structures. More recently, embolization of vascular tumors by interventional radiology has allowed resection of these masses with a lower risk of hemorrhage.[56](B3)

Radiation Therapy

Radiation therapy is rarely used in isolation to treat benign orbital masses. In recent studies, it has been implemented in the treatment of some unresectable or recurrent primary orbital tumors, such as schwannomas and sphenoid wing meningiomas. 

Special Considerations 

Lesions of the orbital apex can result in compressive optic neuropathy and progressive, permanent vision loss. Surgical resection is often difficult in such cases due to challenging anatomy and limited surgical approaches. Orbital decompression has been described as an option in cases and can preserve vision without the need for complete tumor resection and the associated morbidity of orbital apex resection.[57](B2)

Differential Diagnosis

There are a number of other etiologies that may mimic orbital tumors in clinical presentation. The two major categories are infectious and inflammatory diseases. 

Infectious Diseases

  • Orbital cellulitis
  • Orbital tuberculosis
  • Orbital sarcoidosis
  • Histoplasmosis
  • Coccidioidomycosis
  • Mucormycosis/zygomycosis

Inflammatory Diseases 

  • Thyroid orbitopathy/thyroid eye disease
  • Idiopathic orbital inflammation (IOI)
  • IgG4-related disease
  • Amyloidosis
  • Giant cell myositis
  • Optic neuritis

Other Diseases to Consider

  • Orbital fat prolapse
  • Lacrimal gland prolapse
  • Orbital metastasis


The prognosis for benign orbital tumors is often good but can vary depending on the tissue of origin and the tumor location. Long-term morbidity from these lesions stems primarily from the space-occupying effect on surrounding structures, such as the optic nerve.

Benign orbital tumors may be small, discovered incidentally, and/or have an indolent course. However, certain lesions may grow large enough to cause proptosis, direct compression of the globe, optic neuropathy, or diplopia from extraocular muscle restriction. Additionally, the location of the tumor and its proximity to vital structures can impact visual prognosis. Regarding optic nerve sheath meningiomas, for example, surgical resection is often avoided due to the risk of postoperative blindness.[58]


Morbidity and complications from benign orbital tumors primarily stem from their space-occupying effect. Certain vascular tumors, such as orbital varices, may cause spontaneous orbital hemorrhage. Surgical biopsy or surgical excision of orbital masses may result in orbital hemorrhage or damage to vital structures.

Surgical complications vary depending on the type, size, and location of the tumor. Incomplete excision of certain orbital tumors, such as cavernous hemangiomas, may result in recurrence.

Deterrence and Patient Education

Early symptoms of primary benign orbital tumors overlap with those seen in various inflammatory, infectious, and malignant orbital diseases. Thus, it is important to counsel the patient cautiously and empathetically during the diagnostic workup. In cases of small, asymptomatic masses, clinicians should discuss the role of observation and the importance of adherence to follow-up. When intervention is warranted, the risks, benefits, and alternatives should be explained thoroughly to allow informed decision-making.

Enhancing Healthcare Team Outcomes

Primary orbital tumors are very rare. Early signs of orbital mass may be subtle and should be familiar to healthcare professionals inside and outside the field of ophthalmology. Some signs and symptoms of concern include proptosis, vision loss, restriction of extraocular muscle movements, and ptosis. Additionally, providers should become familiar with imaging and histopathologic characteristics of various primary benign orbital tumors. Management of orbital tumors can be complex due to the limited space and various important structures within the orbit. It is important to know when an orbital mass can be observed and when surgical excision is warranted.



Hoang VT,Trinh CT,Nguyen CH,Chansomphou V,Chansomphou V,Tran TTT, Overview of epidermoid cyst. European journal of radiology open. 2019;     [PubMed PMID: 31516916]

Level 3 (low-level) evidence


Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004 May:111(5):997-1008     [PubMed PMID: 15121380]

Level 2 (mid-level) evidence


Devars du Mayne M, Moya-Plana A, Malinvaud D, Laccourreye O, Bonfils P. Sinus mucocele: natural history and long-term recurrence rate. European annals of otorhinolaryngology, head and neck diseases. 2012 Jun:129(3):125-30. doi: 10.1016/j.anorl.2011.10.002. Epub 2012 Jan 5     [PubMed PMID: 22227069]


Ali HM,Khairallah AS,Moghazy K, Acute spontaneous extraconal hematic cyst of the orbit. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2011 Jan;     [PubMed PMID: 23960907]


Yoshikawa K, Fujisawa H, Kajiwara K, Fujii M, Kato S, Akimura T, Nomura S, Gondo T, Suzuki M. Cause of hematic cysts of the orbit: increased fibrinolysis and immunohistologic expression of tissue plasminogen activator. Ophthalmology. 2009 Jan:116(1):130-4. doi: 10.1016/j.ophtha.2008.08.041. Epub 2008 Nov 18     [PubMed PMID: 19019445]

Level 3 (low-level) evidence


Bergin DJ,McCord CD,Dutton JJ,Garrett SN, Chronic hematic cyst of the orbit. Ophthalmic plastic and reconstructive surgery. 1988;     [PubMed PMID: 3154714]

Level 3 (low-level) evidence


Umerani MS,Burhan H,Sharif S,Islam TU,Ghaziani MH, Orbital Meningoencephalocele and Pulsatile Proptosis: A Rare Entity. Cureus. 2018 Jan 15;     [PubMed PMID: 29552427]


Valenzuela AA, Heathcote JG. Apocrine hidrocystoma of the orbit. Orbit (Amsterdam, Netherlands). 2011 Dec:30(6):316-7. doi: 10.3109/01676830.2011.621170. Epub     [PubMed PMID: 22132852]

Level 3 (low-level) evidence


Ssi-Yan-Kai IC,Pearson AR, Recurrent giant orbital apocrine hidrocystoma. Eye (London, England). 2012 Jun;     [PubMed PMID: 22498797]

Level 3 (low-level) evidence


Nassiri N,Rootman J,Rootman DB,Goldberg RA, Orbital lymphaticovenous malformations: Current and future treatments. Survey of ophthalmology. 2015 Sep-Oct;     [PubMed PMID: 26077629]

Level 3 (low-level) evidence


Yamada S, Nakase H, Nakagawa I, Nishimura F, Motoyama Y, Park YS. Cavernous malformations in pregnancy. Neurologia medico-chirurgica. 2013:53(8):555-60     [PubMed PMID: 23979052]

Level 3 (low-level) evidence


Smoker WR, Gentry LR, Yee NK, Reede DL, Nerad JA. Vascular lesions of the orbit: more than meets the eye. Radiographics : a review publication of the Radiological Society of North America, Inc. 2008 Jan-Feb:28(1):185-204; quiz 325. doi: 10.1148/rg.281075040. Epub     [PubMed PMID: 18203938]


Pappas A,Araque JM,Sarup V, Orbital Venous Varices: A Rare Bilateral Asymptomatic Presentation. Cureus. 2018 Sep 14;     [PubMed PMID: 30705795]


Kakhandaki A,Dinesh US,Akash B, Intravascular Papillary Endothelial Hyperplasia as an unusual diagnosis for peri-orbital tumour - A case report. Indian journal of ophthalmology. 2018 Jan;     [PubMed PMID: 29283152]

Level 3 (low-level) evidence


Weber FL, Babel J. Intravascular papillary endothelial hyperplasia of the orbit. The British journal of ophthalmology. 1981 Jan:65(1):18-22     [PubMed PMID: 7448153]

Level 3 (low-level) evidence


Kleihues P,Louis DN,Scheithauer BW,Rorke LB,Reifenberger G,Burger PC,Cavenee WK, The WHO classification of tumors of the nervous system. Journal of neuropathology and experimental neurology. 2002 Mar;     [PubMed PMID: 11895036]


Misra S,Gogri P,Misra N,Bhandari A, Recurrent neurofibroma of the orbit. The Australasian medical journal. 2013;     [PubMed PMID: 23671464]

Level 3 (low-level) evidence


Jaeger MJ, Green WR, Miller NR, Harris GJ. Granular cell tumor of the orbit and ocular adnexae. Survey of ophthalmology. 1987 May-Jun:31(6):417-23     [PubMed PMID: 3039674]

Level 3 (low-level) evidence


Mukai M. Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors. The American journal of pathology. 1983 Aug:112(2):139-46     [PubMed PMID: 6192721]


Salour H,Tavakoli M,Karimi S,Rezaei Kanavi M,Faghihi M, Granular cell tumor of the orbit. Journal of ophthalmic & vision research. 2013 Oct     [PubMed PMID: 24653826]

Level 3 (low-level) evidence


Moseley I. Granular cell tumour of the orbit: radiological findings. Neuroradiology. 1991:33(5):399-402     [PubMed PMID: 1749468]

Level 3 (low-level) evidence


Shapey J, Sabin HI, Danesh-Meyer HV, Kaye AH. Diagnosis and management of optic nerve sheath meningiomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2013 Aug:20(8):1045-56. doi: 10.1016/j.jocn.2013.03.008. Epub 2013 Jun 25     [PubMed PMID: 23809100]


Fathi AR,Roelcke U, Meningioma. Current neurology and neuroscience reports. 2013 Apr;     [PubMed PMID: 23463172]


Solomon DA, Pekmezci M. Pathology of meningiomas. Handbook of clinical neurology. 2020:169():87-99. doi: 10.1016/B978-0-12-804280-9.00005-6. Epub     [PubMed PMID: 32553300]


Wabbels B, Demmler A, Seitz J, Woenckhaus M, Bloss HG, Lorenz B. Unilateral adult malignant optic nerve glioma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2004 Sep:242(9):741-8     [PubMed PMID: 15085353]

Level 3 (low-level) evidence


Zhu B, Yan J. Orbital Paraganglioma. The Journal of craniofacial surgery. 2019 Sep:30(6):e503-e506. doi: 10.1097/SCS.0000000000005408. Epub     [PubMed PMID: 30896513]


Olsen WL,Dillon WP,Kelly WM,Norman D,Brant-Zawadzki M,Newton TH, MR imaging of paragangliomas. AJR. American journal of roentgenology. 1987 Jan;     [PubMed PMID: 3024473]

Level 2 (mid-level) evidence


Furusato E, Valenzuela IA, Fanburg-Smith JC, Auerbach A, Furusato B, Cameron JD, Rushing EJ. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases. Human pathology. 2011 Jan:42(1):120-8. doi: 10.1016/j.humpath.2010.05.021. Epub 2010 Nov 5     [PubMed PMID: 21056898]

Level 3 (low-level) evidence


Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons. Cancers. 2021 Jun 10:13(12):. doi: 10.3390/cancers13122913. Epub 2021 Jun 10     [PubMed PMID: 34200924]


Ulloa TK, Anderson SF. Orbital fibrous histiocytoma: case report and literature review. Journal of the American Optometric Association. 1999 Apr:70(4):253-60     [PubMed PMID: 10457702]

Level 3 (low-level) evidence


Keyserling H,Peterson K,Camacho D,Castillo M, Giant cell angiofibroma of the orbit. AJNR. American journal of neuroradiology. 2004 Aug;     [PubMed PMID: 15313722]

Level 3 (low-level) evidence


Pacheco LF, Fernandes BF, Miyamoto C, Maloney SC, Arthurs B, Burnier MN Jr. Rapid growth of an orbital hemangiopericytoma with atypical histopathological findings. Clinical ophthalmology (Auckland, N.Z.). 2014:8():31-3. doi: 10.2147/OPTH.S47901. Epub 2013 Dec 10     [PubMed PMID: 24353402]

Level 3 (low-level) evidence


Morrow NC, Tanas MR, Syed NA, Rajan Kd A. Solitary adult orbital myofibroma: Report of a case and review of the literature. American journal of ophthalmology case reports. 2020 Dec:20():100955. doi: 10.1016/j.ajoc.2020.100955. Epub 2020 Oct 9     [PubMed PMID: 33089011]

Level 3 (low-level) evidence


Ricalde P, Horswell BB. Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2001 Feb:59(2):157-67; discussion 167-8     [PubMed PMID: 11213984]

Level 2 (mid-level) evidence


Katz BJ,Nerad JA, Ophthalmic manifestations of fibrous dysplasia: a disease of children and adults. Ophthalmology. 1998 Dec;     [PubMed PMID: 9855148]

Level 3 (low-level) evidence


Wei LA, Ramey NA, Durairaj VD, Ramakrishnan VR, Cruz AV, Dolman PJ, Lucarelli MJ. Orbital osteoma: clinical features and management options. Ophthalmic plastic and reconstructive surgery. 2014 Mar-Apr:30(2):168-74. doi: 10.1097/IOP.0000000000000039. Epub     [PubMed PMID: 24614547]

Level 3 (low-level) evidence


Rabelo N, da Silva VTG, do Espírito Santo MP, Solla D, Oberman DZ, da Costa BS, Frassetto FP, Teixeira MJ, Figueiredo EG. Orbit ossifying fibroma - Case report and literature review. Surgical neurology international. 2020:11():35. doi: 10.25259/SNI_492_2019. Epub 2020 Feb 28     [PubMed PMID: 32257561]

Level 3 (low-level) evidence


Kabra RS, Patel SB, Shanbhag SS. Orbital Chondroma: A rare mesenchymal tumor of orbit. Indian journal of ophthalmology. 2015 Jun:63(6):551-4. doi: 10.4103/0301-4738.162638. Epub     [PubMed PMID: 26265654]


Mercado GV, Shields CL, Gunduz K, Shields JA, Eagle RC Jr. Giant cell reparative granuloma of the orbit. American journal of ophthalmology. 1999 Apr:127(4):485-7     [PubMed PMID: 10218717]

Level 3 (low-level) evidence


Bengoa-González Á, Mencía-Gutiérrez E, Alonso-Martín B, Laslău BM, Salvador E, Enguita-Valls AB, Lago-Llinás MD. Giant Cell Reparative Granuloma of the Orbit: Clinicopathological Characteristics and Treatment. Case reports in ophthalmological medicine. 2021:2021():4917968. doi: 10.1155/2021/4917968. Epub 2021 May 27     [PubMed PMID: 34136295]

Level 3 (low-level) evidence


Reis C, Lopes JM, Carneiro E, Vilarinho A, Portugal R, Duarte F, Fonseca J. Temporal giant cell reparative granuloma: a reappraisal of pathology and imaging features. AJNR. American journal of neuroradiology. 2006 Sep:27(8):1660-2     [PubMed PMID: 16971609]

Level 3 (low-level) evidence


Kim E, Kim HJ, Kim YD, Woo KI, Lee H, Kim ST. Subconjunctival fat prolapse and dermolipoma of the orbit: differentiation on CT and MR imaging. AJNR. American journal of neuroradiology. 2011 Mar:32(3):465-7. doi: 10.3174/ajnr.A2313. Epub 2010 Dec 16     [PubMed PMID: 21163882]


McNab AA, Wright JE, Caswell AG. Clinical features and surgical management of dermolipomas. Australian and New Zealand journal of ophthalmology. 1990 May:18(2):159-62     [PubMed PMID: 2390243]


de Smet MD, Rootman J. Orbital manifestations of plasmacytic lymphoproliferations. Ophthalmology. 1987 Aug:94(8):995-1003     [PubMed PMID: 3658377]

Level 3 (low-level) evidence


Westacott S, Garner A, Moseley IF, Wright JE. Orbital lymphoma versus reactive lymphoid hyperplasia: an analysis of the use of computed tomography in differential diagnosis. The British journal of ophthalmology. 1991 Dec:75(12):722-5     [PubMed PMID: 1768660]

Level 2 (mid-level) evidence


Klavdianou O, Kondylis G, Georgopoulos V, Palioura S. Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: a case treated with oral doxycycline and review of the literature. Eye and vision (London, England). 2019:6():26. doi: 10.1186/s40662-019-0151-4. Epub 2019 Sep 2     [PubMed PMID: 31497614]

Level 3 (low-level) evidence


Chen A, Hwang TN, Phan LT, McCulley TJ, Yoon MK. Long-term management of orbital and systemic reactive lymphoid hyperplasia with rituximab. Middle East African journal of ophthalmology. 2012 Oct:19(4):432-5. doi: 10.4103/0974-9233.102770. Epub     [PubMed PMID: 23248552]

Level 3 (low-level) evidence


Markowski J, Jagosz-Kandziora E, Likus W, Pająk J, Mrukwa-Kominek E, Paluch J, Dziubdziela W. Primary orbital tumors: a review of 122 cases during a 23-year period: a histo-clinical study in material from the ENT Department of the Medical University of Silesia. Medical science monitor : international medical journal of experimental and clinical research. 2014 Jun 16:20():988-94. doi: 10.12659/MSM.890433. Epub 2014 Jun 16     [PubMed PMID: 24930391]

Level 3 (low-level) evidence


Bonavolontà G, Strianese D, Grassi P, Comune C, Tranfa F, Uccello G, Iuliano A. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic plastic and reconstructive surgery. 2013 Mar-Apr:29(2):79-86. doi: 10.1097/IOP.0b013e31827a7622. Epub     [PubMed PMID: 23470516]

Level 2 (mid-level) evidence


Patel BC, De Jesus O, Margolin E. Optic Nerve Sheath Meningioma. StatPearls. 2023 Jan:():     [PubMed PMID: 28613618]


Agarwal A, Raut AA. Orbital Vascular Anomalies. StatPearls. 2023 Jan:():     [PubMed PMID: 35201701]


Alruwaili AA, De Jesus O. Meningioma. StatPearls. 2023 Jan:():     [PubMed PMID: 32809373]


Gandhi NG, Lin LK, O'Hara M. Sildenafil for pediatric orbital lymphangioma. JAMA ophthalmology. 2013 Sep:131(9):1228-30. doi: 10.1001/jamaophthalmol.2013.4201. Epub     [PubMed PMID: 23828510]

Level 3 (low-level) evidence


Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. The New England journal of medicine. 2012 Jan 26:366(4):384-6. doi: 10.1056/NEJMc1112482. Epub     [PubMed PMID: 22276841]

Level 3 (low-level) evidence


Lagrèze WA, Joachimsen L, Gross N, Taschner C, Rössler J. Sirolimus-induced regression of a large orbital lymphangioma. Orbit (Amsterdam, Netherlands). 2019 Feb:38(1):79-80. doi: 10.1080/01676830.2018.1436569. Epub 2018 Feb 6     [PubMed PMID: 29405800]


Ooi KG, Wenderoth JD, Francis IC, Wilcsek GA. Selective embolization and resection of a large noninvoluting congenital hemangioma of the lower eyelid. Ophthalmic plastic and reconstructive surgery. 2009 Mar-Apr:25(2):111-4. doi: 10.1097/IOP.0b013e318199dba5. Epub     [PubMed PMID: 19300152]

Level 3 (low-level) evidence


Kloek CE, Bilyk JR, Pribitkin EA, Rubin PA. Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex. Ophthalmology. 2006 Jul:113(7):1214-9     [PubMed PMID: 16815404]

Level 2 (mid-level) evidence


Schick U, Dott U, Hassler W. Surgical management of meningiomas involving the optic nerve sheath. Journal of neurosurgery. 2004 Dec:101(6):951-9     [PubMed PMID: 15597756]

Level 2 (mid-level) evidence